- Report
- February 2023
- 732 Pages
Global
From €4718EUR$4,950USD£4,047GBP
- Report
- December 2020
- 148 Pages
Global
From €1311EUR$1,375USD£1,124GBP
€2621EUR$2,750USD£2,248GBP
- Report
- April 2024
- 241 Pages
From €5671EUR$5,950USD£4,865GBP
- Report
- April 2023
- 105 Pages
Europe
From €4527EUR$4,750USD£3,884GBP
- Report
- May 2024
- 200 Pages
From €3955EUR$4,150USD£3,393GBP
- Report
- August 2019
- 44 Pages
Global
From €4761EUR$4,995USD£4,084GBP
- Report
- December 2022
- 59 Pages
China
From €4761EUR$4,995USD£4,084GBP
The Small Molecule API market is a subset of the Drug Discovery market, which focuses on the development of new drugs and treatments. Small Molecule APIs are active pharmaceutical ingredients (APIs) that are synthesized from small molecules. These molecules are used to create drugs that can be used to treat a variety of diseases. Small Molecule APIs are used in the early stages of drug discovery, as they can be used to identify potential drug targets and to develop drug candidates. They are also used in the later stages of drug development, such as preclinical and clinical trials.
The Small Molecule API market is highly competitive, with many companies offering a wide range of products and services. Some of the major players in the market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Eli Lilly. Show Less Read more
